Intranasal administration of elastin-like polypeptide for therapeutic delivery to the central nervous system

References

• DhuriaSVHansonLRFreyWH2ndIntranasal delivery to the central nervous system: mechanisms and experimental considerationsJ Pharm Sci20109941654167319877171
   PubMed Web of Science ®Google Scholar
• XuJXiangQSuJEvaluation of the safety and brain-related tissues distribution characteristics of TAT-HaFGF via intranasal administrationBiol Pharm Bull20143771149115724989006
   PubMed Web of Science ®Google Scholar
• FalconeJASalamehTSYiXIntranasal administration as a route for drug delivery to the brain: evidence for a unique pathway for albuminJ Pharmacol Exp Ther20143511546025027317
   PubMed Web of Science ®Google Scholar
• YangJPLiuHJChengSMDirect transport of VEGF from the nasal cavity to brainNeurosci Lett2009449210811118996442
   PubMed Web of Science ®Google Scholar
• CasettariLIllumLChitosan in nasal delivery systems for therapeutic drugsJ Control Release201419018920024818769
   PubMed Web of Science ®Google Scholar
• YangZZZhangYQWangZZWuKLouJNQiXREnhanced brain distribution and pharmacodynamics of rivastigmine by liposomes following intranasal administrationInt J Pharm20134521–234435423680731
   PubMed Web of Science ®Google Scholar
• BidwellGL3rdFoktIPriebeWRaucherDDevelopment of elastin-like polypeptide for thermally targeted delivery of doxorubicinBiochem Pharmacol200773562063117161827
   PubMed Web of Science ®Google Scholar
• GeorgeEMLiuHRobinsonGGMahdiFPerkinsEBidwellGL3rdGrowth factor purification and delivery systems (PADS) for therapeutic angiogenesisVasc Cell201571125653833
   PubMedGoogle Scholar
• ShamjiMFWhitlatchLFriedmanAHRichardsonWJChilkotiASettonLAAn injectable and in situ-gelling biopolymer for sustained drug release following perineural administrationSpine (Phila Pa 1976)200833774875418379401
   PubMed Web of Science ®Google Scholar
• GeorgeEMLiuHRobinsonGGBidwellGLA polypeptide drug carrier for maternal delivery and prevention of fetal exposureJ Drug Target2014221093594725148609
   PubMed Web of Science ®Google Scholar
• NicolAGowdaCUrryDWElastic protein-based polymers as cell attachment matricesJ Vasc Surg19911357467482027224
   PubMed Web of Science ®Google Scholar
• ZhangYNAveryRKVallmajo-MartinQA highly elastic and rapidly crosslinkable elastin-like polypeptide-based hydrogel for biomedical applicationsAdv Funct Mater201525304814482626523134
   PubMed Web of Science ®Google Scholar
• MoktanSPerkinsEKratzFRaucherDThermal targeting of an acid-sensitive doxorubicin conjugate of elastin-like polypeptide enhances the therapeutic efficacy compared with the parent compound in vivoMol Cancer Ther20121171547155622532601
   PubMed Web of Science ®Google Scholar
• LiuWDreherMRChowDCZalutskyMRChilkotiATracking the in vivo fate of recombinant polypeptides by isotopic labelingJ Control Release2006114218419216904221
   PubMed Web of Science ®Google Scholar
• HearstSMShaoQLopezMRaucherDVigPJSThe design and delivery of a PKA inhibitory polypeptide to treat SCA1J Neurochem2014131110111424903464
   PubMed Web of Science ®Google Scholar
• KameiNTakeda-MorishitaMBrain delivery of insulin boosted by intranasal coadministration with cell-penetrating peptidesJ Control Release201519710511025445695
   PubMed Web of Science ®Google Scholar
• Khafagyel-SMorishitaMTakayamaKThe role of intermolecular interactions with penetratin and its analogue on the enhancement of absorption of nasal therapeutic peptidesInt J Pharm20103881–220921220060451
   PubMedGoogle Scholar
• SkotlandTIversenTTorgersenMSandvigKCell-penetrating peptides: possibilities and challenges for drug delivery in vitro and in vivoMolecules2015207133131332326205056
   PubMed Web of Science ®Google Scholar
• KanazawaTAkiyamaFKakizakiSTakashimaYSetaYDelivery of siRNA to the brain using a combination of nose-to-brain delivery and cell-penetrating peptide-modified nano-micellesBiomaterials201334369220922623992922
   PubMed Web of Science ®Google Scholar
• SilholMTyagiMGiaccaMLebleuBVivèsEDifferent mechanisms for cellular internalization of the HIV-1 Tat-derived cell penetrating peptide and recombinant proteins fused to TatEur J Biochem2002269249450111856307
   PubMedGoogle Scholar
• RousselleCClairPLefauconnierJMKaczorekMScherrmannJMTemsamaniJNew advances in the transport of doxorubicin through the blood-brain barrier by a peptide vector-mediated strategyMol Pharmacol200057467968610727512
   PubMed Web of Science ®Google Scholar
• BidwellGL3rdDavisANRaucherDTargeting a c-Myc inhibitory polypeptide to specific intracellular compartments using cell penetrating peptidesJ Control Release2009135121019095020
   PubMed Web of Science ®Google Scholar
• WalkerLRPerkinsEMcNallyLRRaucherDFusion of cell-penetrating peptides to thermally responsive biopolymer improves tumor accumulation of p21 peptide in a mouse model of pancreatic cancerDrug Des Devel Ther2014816491658
   PubMed Web of Science ®Google Scholar
• WangZChenYLiuEGongJShinMCHuangYCPP-mediated protein delivery in a noncovalent form: proof-of-concept for percutaneous and intranasal deliveryProtein Pept Lett201421111129113625106905
   PubMed Web of Science ®Google Scholar
• LyonsDFLeVHKramerWHThe effect of basic cell penetrating peptides on the structural, thermodynamic and hydrodynamic properties of a novel drug delivery vector: ELP [V5G3A2-150]Biochemistry20145361081109124450599
   PubMed Web of Science ®Google Scholar
• BidwellGLPerkinsEHughesJKhanMJamesJRRaucherDThermally targeted delivery of a c-Myc inhibitory polypeptide inhibits tumor progression and extends survival in a rat glioma modelPLoS One201381e5510423372821
   PubMed Web of Science ®Google Scholar
• SelaHCohenHEliaPZachRKarpasZZeiriYSpontaneous penetration of gold nanoparticles through the blood brain barrier (BBB)J Nanobiotechnology2015137126489846
   PubMed Web of Science ®Google Scholar
• StockwellJAbdiNLuXMaheshwariOTaghibiglouCNovel central nervous system drug delivery systemsChem Biol Drug Des201483550752024325540
   PubMed Web of Science ®Google Scholar
• KimJSYoonTJYuKNToxicity and tissue distribution of magnetic nanoparticles in miceToxicol Sci200689133834716237191
   PubMed Web of Science ®Google Scholar
• LovisoloDGilardinoARuffinattiFWhen neurons encounter nanoobjects: spotlight on calcium signallingInt J Environ Res Public Health20141199621963725229698
   PubMed Web of Science ®Google Scholar
• RuigrokMJRde LangeECMEmerging insights for translational pharmacokinetic and pharmacokinetic-pharmacodynamic studies: towards prediction of nose-to-brain transport in humansAAPS J201517349350525693488
   PubMed Web of Science ®Google Scholar
• CraftSBakerLDMontineTJIntranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairmentArch Neurol2012691293821911655
   PubMed Web of Science ®Google Scholar
• ChadeARTullosNAHarveyTWMahdiFBidwellGL3rdRenal therapeutic angiogenesis using a bioengineered polymer-stabilized vascular endothelial growth factor constructJ Am Soc Nephrol20162761741175226541349
   PubMed Web of Science ®Google Scholar
• VigPJSSubramonySHD’SouzaDRWeiJLopezMEIntranasal administration of IGF-I improves behavior and Purkinje cell pathology in SCA1 miceBrain Res Bull200669557357916647585
   PubMed Web of Science ®Google Scholar
• VigPJHearstSShaoQLopezMEMurphyHA2ndSafayaEGlial S100B protein modulates mutant ataxin-1 aggregation and toxicity: TRTK12 peptide, a potential candidate for SCA1 therapyCerebellum201110225426621384195
   PubMed Web of Science ®Google Scholar